Helius Medical Technologies, Inc. (HSDT) Tops Q2 EPS by 6c

Helius Medical Technologies, Inc. (NASDAQ: HSDT) reported Q2 EPS of ($0.06), $0.06 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $250 thousand versus the consensus estimate of $188.33 thousand.

For earnings history and earnings-related data on Helius Medical Technologies, Inc. (HSDT) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance